News, Press Releases, and Media Inquiries

Tender Corp.’s QuikClot® Nosebleed™ Offers Fast, Effective Treatment of Nasal Bleeding

May 1, 2009 - LITTLETON, NH
LITTLETON, NH (MAY 1ST, 2009) -- Tender Corp., a leading developer of topical cream and first aid products designed to enhance consumers’ lives, today announced the release of QuickClot® Nosebleed™ -- a hemostatic product that stops nosebleeds fast.

The FDA-approved QuikClot® NoseBleed™ consists of gauze packing impregnated with a specially formulated mineral substance, called Kaolin, which activates factors in blood to promote rapid blood coagulation. The easy-to-apply packing is rolled or folded to fit into an affected nostril. Once inserted and pressure is applied, QuikClot® Nosebleed will stop the bleeding in five minutes. By contrast, competing nosebleed products, which are ostensibly cotton pads or packing, take between 10 minutes to 30 minutes to work. These products try to stop the bleeding by absorbing the blood, making it likely for bleeds to re-occur.

NASAL BLEEDING A COMMON AILMENT, ESPECIALLY DURING WINTER

There are various causes of nosebleeds, but the most common factors include trauma to the nose and exposure to cold, dry climates. Most nosebleeds occur during winter months, when the air is cold and dry -- conditions that make the nasal membranes more susceptible to cracking and drying out. Every year in the United States, there are close to 400 million nosebleeds. While many nosebleeds are minor, about 515,000 result in visits to hospital emergency departments1 -- stressful, time consuming and expensive incidents. While anyone can suffer a nosebleed, they most frequently strike two age groups -- children under ten years old and seniors.

“With QuikClot Nosebleed, Tender Corp. is helping make a difference for parents and caregivers who have to treat their children and loved ones who suffer from this most common of ailments,” said Tender CEO Jason Cartwright. 

He continued, “Whether the bleeding is the result of an accident, sports injury or if someone is just predisposed to the condition, QuickClot Nosebleed will provide the fastest and safest solution to stopping serious nosebleeds.”
Safe for all ages, QuikClot® Nosebleed™ consists of five sterile applications and retails for MSRP$11.49. The product is currently available at Kroger Foods and Fred Meyer, among other leading food, drug and mass retail outlets.

QuikClot® Nosebleed™ was developed by Z-Medica Corp., which produces a variety of products designed to stop traumatic bleeding, which it sells to the military, law enforcement, hospital and emergency medical services markets. In addition to Nosebleed™, Tender Corp. maintains the exclusive distribution rights to Z-Medica’s QuikClot® Travel, QuikClot® Home, QuikClot® Sport and QuikClot® Sport Silver for food, drug, mass, and sporting goods retail channels.

For more information on Tender’s line of QuikClot® products, visit www.tendercorp.com

About Tender Corporation
Tender Corporation is a privately owned and operated business located in the heart of the White Mountains in Littleton, NH. The company maintains offices and distribution centers in Barrie, Ontario; Rotterdam, Holland; Newbury, England; and Oakland, California. Currently, its products are distributed in over 40 countries. Founded in 1975, the firm manufactures and markets the world-famous insect bite treatment, After Bite® -- The Itch Eraser™, a full line of well-known insect repellents, first-aid treatments, sunburn and windburn products, as well as activity-specific first aid kits and survival gear through its outdoor division Adventure® Medical Kits.        
      More recently, Tender has established exclusive partnerships with Z-Medica® (maker of the hemostatic product QuikClot®) and Strategic Science Technologies, LLC (maker of the foot moisturizing cream HealthiFeet®) to distribute their products through various retail channels. The company also maintains a contract packaging division, which produces OTC products for a variety of clients. Many of Tender’s products are packaged in innovative ways that make them extremely convenient to use as well as environmentally responsible. Partial proceeds from the sale of the company’s products go to Tender Corporation’s Environmental Scholarship Fund. Complete product information is available on the company's web site: www.tendercorp.com

About Z-Medica
Founded in April 2002, Z-Medica Corporation is a medical products company focused on innovative blood clotting technologies -- hemostatic solutions that save lives. QuikClot® was developed in cooperation with the Office of Naval Research (ONR), the U.S. Marine Corps Warfighting Laboratory, the U.S. Marine Corps Systems Command and university hospitals. It represents the first and most effective solution to severe blood loss outside the operating room setting. Z-Medica serves several global vertical markets, including military, first responder, homeland and private security. The company is fully engaged in accelerating development and distribution of QuikClot® hemostatic agent, QuikClot ACS™ and related products. For more information, visit: www.z-medica.com

PR Contact:
Simon Ashdown
Tender Corp.
T: 905.763.7137 M: 416.560.9016
E: sashdown@tendercorp.com
FIND A RETAILER  •  USAGE & STORAGE INFO  •  BUG FACTS, TIPS & DOWNLOADS  •  FAQ's  •  ABOUT US  •  PRESS RELEASES 
Contract Packaging | Tender Corp. Canada | AMK | Site Map | Dragon Heat Survey

©2010 All Rights Reserved. Tender Corporation - 106 Burndy Road, Littleton, NH 03561

Toll-free: 1-800-258-4696 - Phone: (603) 444-5464 - Fax: (603) 444-6735